- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 5/0784 - Cellules dendritiquesLeurs progéniteurs
Détention brevets de la classe C12N 5/0784
Brevets de cette classe: 1190
Historique des publications depuis 10 ans
|
95
|
102
|
90
|
76
|
99
|
80
|
85
|
85
|
81
|
51
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Yale University | 2533 |
27 |
| Flaskworks, LLC | 47 |
26 |
| Transimmune AG | 30 |
21 |
| The Regents of the University of California | 20745 |
18 |
| Baylor Research Institute | 225 |
17 |
| Asgard Therapeutics AB | 21 |
16 |
| Baylor College of Medicine | 1002 |
14 |
| Oncotherapy Science, Inc. | 242 |
12 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3304 |
12 |
| University of Florida Research Foundation, Inc. | 4174 |
11 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3001 |
11 |
| Northwest Biotherapeutics, Inc. | 27 |
10 |
| Board of Regents, The University of Texas System | 6107 |
9 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 1021 |
9 |
| Immunicum AB | 13 |
9 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3335 |
9 |
| Universite de Montreal | 349 |
9 |
| PrimeVax Immuno-Oncology, Inc. | 13 |
9 |
| FUJIFILM Cellular Dynamics, Inc. | 151 |
9 |
| Hryz (Guangzhou) Biotech Co. | 13 |
9 |
| Autres propriétaires | 923 |